Entecavir: a potent antiviral with minimal long-term resistance in nucleoside-naive chronic hepatitis B patients.
about
De novo combination of lamivudine and adefovir versus entecavir monotherapy for the treatment of naïve HBeAg-negative chronic hepatitis B patientsMultiple Drug Transporters Are Involved in Renal Secretion of Entecavir.Recent advances in prevention of hepatitis B recurrence after liver transplantation.Impact of hepatitis B e antigen-suppressing mutations on the replication efficiency of entecavir-resistant hepatitis B virus strains.Synthesis and Quantitative Structure-activity Relationships Study for Arylpropenamide Derivatives as Inhibitors of Hepatitis B Virus Replication.The risk of hepatitis B virus reactivation and the role of antiviral prophylaxis in hepatitis B surface antigen negative/hepatitis B core antibody positive patients with diffuse large B-cell lymphoma receiving rituximab-based chemotherapy.Laboratory evaluation of three regimens of treatment of chronic hepatitis B: tenofovir, entecavir and combination of lamivudine and adefovirRisk of hepatitis B virus (HBV) reactivation in hepatitis B surface antigen negative/hepatitis B core antibody positive patients receiving rituximab-containing combination chemotherapy without routine antiviral prophylaxis.Efficacy and Safety of Entecavir 0. 5 mg in Treating Naive Chronic Hepatitis B Virus Patients in Egypt: Five Years of Real Life Experience.
P2860
Q34959519-67E1CCB2-7510-4134-9B05-0A6C35AE1561Q37287773-39BAA6DB-EF31-422E-83DF-68503309F7B9Q38333875-5201C1B3-CE60-42C0-906B-E369C73384B0Q39649139-3FD80C96-FF79-454D-BBB1-45FFB4005992Q39845532-394EAB16-ADC0-42B3-BF09-C1683BFE12AEQ42203535-6A65BEAD-8F07-4B50-AB51-C6125225FC75Q42224266-D7FB17E8-E415-4BA6-B004-03630DAA6EC5Q45367090-AC42EE2A-32F7-4B1A-8370-4B074068CE1CQ55364394-CE1C41F4-3009-459A-A514-B970260D35C0
P2860
Entecavir: a potent antiviral with minimal long-term resistance in nucleoside-naive chronic hepatitis B patients.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Entecavir: a potent antiviral ...... chronic hepatitis B patients.
@en
Entecavir: a potent antiviral ...... chronic hepatitis B patients.
@nl
type
label
Entecavir: a potent antiviral ...... chronic hepatitis B patients.
@en
Entecavir: a potent antiviral ...... chronic hepatitis B patients.
@nl
prefLabel
Entecavir: a potent antiviral ...... chronic hepatitis B patients.
@en
Entecavir: a potent antiviral ...... chronic hepatitis B patients.
@nl
P2860
P356
P1476
Entecavir: a potent antiviral ...... chronic hepatitis B patients.
@en
P2093
Pin-Nan Cheng
Ting-Tsung Chang
P2860
P304
P356
10.1586/14787210.6.5.569
P577
2008-10-01T00:00:00Z